US90274B7745

Lyfecycle: Early Matured |  Fair Value: Sign-in

Contingent Income Autocallable on Celgene - 10.11.2017

Summary

This is a 3 year autocall paying in US Dollars issued by UBS AG linked to the performance of Celgene Corp between 11/7/2014 and 11/7/2017. Although the latest maturity date is 11/7/2017, the product will be monitored at quarterly periods. The product will mature early if at any quarterly date, from period 1, the worst performing underlying is at or above 100% of its initial level (at the relevant date). In which case, the product will repay the initial investment plus a coupon of 2.425% (at the relevant date when the autocall is triggered). Otherwise the product will pay a coupon of 2.425% if the underlying is at or above the 80% of its initial level. If the product runs to maturity, the product will repay the initial investment plus a coupon of 2.425% so long as the worst performing underlying is at or above 80%. Otherwise the product will repay the initial investment less any negative worst performing underlying measured over the term of the product

 Key Investment Document (KID)


Product Sheet

Free Sign-in to view contract terms.






 More options and tools

  • Need more detailed information including backtesting, what-if analysis, greeks or the Fairmat independent quantitative report? Request an on-demand analytics.
  • Want to assess a custom product similar to this one? Clone this product and modify it.
  • Want to Find, Compare and Rank Similar Products?  Sign-in to access the  Products Ranking And Comparison Tools.

This product have been mapped on /USA/2014 and have been modelled using the template /Structured Products/Autocall



Disclaimer: this product sheet has been created by Fairmat Srl and its partners using public available information, hence it represents our interpretation of the product. The information displayed in this page does not represent any recommendation to buy or sell the displayed product.